NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Status:
Completed
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Our primary objective is to determine if it is feasible for previously untreated severe
aplastic anemia (SAA) patients to be transplanted using non-myeloablative conditioning and
post transplantation cyclophosphamide.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins